1 |
Wilson FH, Disse-Nicodeme S, Choate KA, Ishikawa K, Nelson-Williams C, Desitter I, et al. Human hypertension caused by mutations in WNK kinases. Science 2001;293:1107-12.
DOI
ScienceOn
|
2 |
Boyden LM, Choi M, Choate KA, Nelson-Williams CJ, Farhi A, Toka HR, et al. Mutations in Kelch-like 3 and Cullin 3 cause hypertension and electrolyte abnormalities. Nature 2012;482:98-102.
DOI
ScienceOn
|
3 |
Bülchmann G, Schuster T, Heger A, Kuhnle U, Joppich I, Schmidt H. Transient pseudohypoaldosteronism secondary to posterior urethral valves - a case report and review of the literature. Eur J Pediatr Surg 2001;11:277-9.
DOI
ScienceOn
|
4 |
DuBose TD Jr. Molecular and pathophysiologic mechanisms of hyperkalemic metabolic acidosis. Trans Am Clin Climatol Assoc 2000;111:122-33.
|
5 |
Pujo L, Fagart J, Gary F, Papadimitriou DT, Claës A, Jeunemaître X, et al. Mineralocorticoid receptor mutations are the principal cause of renal type 1 pseudohypoaldosteronism. Hum Mutat 2007;28:33-40.
DOI
ScienceOn
|
6 |
Riepe FG, Finkeldei J, de Sanctis L, Einaudi S, Testa A, Karges B, et al. Elucidating the underlying molecular pathogenesis of NR3C2 mutants causing autosomal dominant pseudohypoaldosteronism type 1. J Clin Endocrinol Metab 2006;91:4552-61.
DOI
ScienceOn
|
7 |
Lee SE, Jung YH, Han KH, Lee HK, Kang HG, Ha IS, et al. A case of pseudohypoaldosteronism type 1 with a mutation in the mineralocorticoid receptor gene. Korean J Pediatr 2011;54:90-3.
DOI
ScienceOn
|
8 |
Sartorato P, Khaldi Y, Lapeyraque AL, Armanini D, Kuhnle U, Salomon R, et al. Inactivating mutations of the mineralocorticoid receptor in Type I pseudohypoaldosteronism. Mol Cell Endocrinol 2004;217:119-25.
DOI
ScienceOn
|
9 |
Tajima T, Kitagawa H, Yokoya S, Tachibana K, Adachi M, Nakae J, et al. A novel missense mutation of mineralocorticoid receptor gene in one Japanese family with a renal form of pseudohypoaldosteronism type 1. J Clin Endocrinol Metab 2000;85:4690-4.
DOI
|
10 |
Riepe FG, Krone N, Morlot M, Peter M, Sippell WG, Partsch CJ. Autosomal- dominant Pseudohypoaldosteronism type 1 in a Turkish family is associated with a novel nonsense mutation in the human mineralocorticoid receptor gene. J Clin Endocrinol Metab 2004;89:2150-2.
DOI
|
11 |
Chang SS, Grunder S, Hanukoglu A, Rösler A, Mathew PM, Hanukoglu I, et al. Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1. Nat Genet 1996;12:248-53.
DOI
ScienceOn
|
12 |
Strautnieks SS, Thompson RJ, Gardiner RM, Chung E. A novel splicesite mutation in the gamma subunit of the epithelial sodium channel gene in three pseudohypoaldosteronism type 1 families. Nat Genet 1996;13:248-50.
DOI
ScienceOn
|
13 |
Oberfield SE, Levine LS, Carey RM, Bejar R, New MI. Pseudohypoaldosteronism: multiple target organ unresponsiveness to mineralocorticoid hormones. J Clin Endocrinol Metab 1979;48:228-34.
DOI
|
14 |
Narchi H, Santos M, Kulaylat N. Polyhydramnios as a sign of fetal pseudohypoaldosteronism. Int J Gynaecol Obstet 2000;69:53-4.
DOI
ScienceOn
|
15 |
Velázquez H, Silva T, Andújar E, Desir GV, Ellison DH, Greger R. The distal convoluted tubule of rabbit kidney does not express a functional sodium channel. Am J Physiol Renal Physiol 2001;280:F530-9.
DOI
|
16 |
Hayama A, Rai T, Sasaki S, Uchida S. Molecular mechanisms of Bartter syndrome caused by mutations in the BSND gene. Histochem Cell Biol 2003;119:485-93.
DOI
|
17 |
Shayakul C, Alper SL. Defects in processing and trafficking of the AE1 exchanger associated with inherited distal renal tubular acidosis. Clin Exp Nephrol 2004;8:1-11.
DOI
|
18 |
Wagner CA, Mohebbi N, Capasso G, Geibel JP. The anion exchanger pendrin (SLC26A4) and renal acid-base homeostasis. Cell Physiol Biochem 2011;28:497-504.
DOI
ScienceOn
|
19 |
Geller DS. Mineralocorticoid resistance. Clin Endocrinol (Oxf) 2005; 62:513-20.
DOI
ScienceOn
|
20 |
Hanukoglu A. Type I pseudohypoaldosteronism includes two clinically and genetically distinct entities with either renal or multiple target organ defects. J Clin Endocrinol Metab 1991;73:936-44.
DOI
|
21 |
Riepe FG. Pseudohypoaldosteronism. Endocr Dev 2013;24:86-95.
DOI
ScienceOn
|
22 |
Kostakis ID, Cholidou KG, Perrea D. Syndromes of impaired ion handling in the distal nephron: pseudohypoaldosteronism and familial hyperkalemic hypertension. Hormones 2012;11:31-53.
|
23 |
Sartorato P, Lapeyraque AL, Armanini D, Kuhnle U, Khaldi Y, Salomon R, et al. Different inactivating mutations of the mineralocorticoid receptor in fourteen families affected by type I pseudohypoaldosteronism. J Clin Endocrinol Metab 2003;88:2508-17.
DOI
ScienceOn
|
24 |
Sartorato P, Cluzeaud F, Fagart J, Viengchareun S, Lombès M, Zennaro MC. New naturally occurring missense mutations of the human mineralocorticoid receptor disclose important residues involved in dynamic interactions with deoxyribonucleic acid, intracellular trafficking, and ligand binding. Mol Endocrinol 2004;18:2151-65.
DOI
ScienceOn
|
25 |
Geller DS, Rodriguez-Soriano J, Vallo Boado A, Schifter S, Bayer M, Chang SS, et al. Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I. Nat Genet 1998;19:279-81.
DOI
ScienceOn
|
26 |
Quinn SJ, Williams GH. Regulation of aldosterone secretion. Annu Rev Physiol 1988;50:409-26.
DOI
ScienceOn
|
27 |
Spät A, Hunyady L. Control of aldosterone secretion: a model for convergence in cellular signaling pathways. Physiol Rev 2004;84:489-539.
DOI
ScienceOn
|
28 |
Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE, et al. Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 1987;237:268-75.
DOI
|
29 |
Funder JW, Pearce PT, Smith R, Smith AI. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 1988; 242:583-5.
DOI
|
30 |
Quinkler M, Stewart PM. Hypertension and the cortisol-cortisone shuttle. J Clin Endocrinol Metab 2003;88:2384-92.
DOI
ScienceOn
|
31 |
Mick VE, Itani OA, Loftus RW, Husted RF, Schmidt TJ, Thomas CP. The alpha-subunit of the epithelial sodium channel is an aldosteroneinduced transcript in mammalian collecting ducts, and this transcriptional response is mediated via distinct cis-elements in the 5'-flanking region of the gene. Mol Endocrinol 2001;15:575-88.
|
32 |
Alvarez de la Rosa D, Canessa CM, Fyfe GK, Zhang P. Structure and regulation of amiloride-sensitive sodium channels. Annu Rev Physiol 2000;62:573-94.
DOI
ScienceOn
|
33 |
Garty H, Palmer LG. Epithelial sodium channels: function, structure, and regulation. Physiol Rev 1997;77:359-96.
DOI
|
34 |
Wang W. Renal potassium channels: recent developments. Curr Opin Nephrol Hypertens 2004;13:549-55.
DOI
ScienceOn
|
35 |
Woda CB, Bragin A, Kleyman TR, Satlin LM. Flow-dependent K+ secretion in the cortical collecting duct is mediated by a maxi-K channel. Am J Physiol Renal Physiol 2001;280:F786-93.
|
36 |
Liu W, Xu S, Woda C, Kim P, Weinbaum S, Satlin LM. Effect of flow and stretch on the [Ca2+]i response of principal and intercalated cells in cortical collecting duct. Am J Physiol Renal Physiol 2003;285:F998- 1012.
DOI
|
37 |
Wingo CS, Smolka AJ. Function and structure of H-K-ATPase in the kidney. Am J Physiol 1995;269(1 Pt 2):F1-16.
DOI
|
38 |
Uchida S, Sasaki S. Function of chloride channels in the kidney. Annu Rev Physiol 2005;67:759-78.
DOI
ScienceOn
|
39 |
Fuller PJ, Young MJ. Mechanisms of mineralocorticoid action. Hypertension 2005;46:1227-35.
DOI
ScienceOn
|
40 |
Ellison DH, Thomas CP. Chap. 16. Hereditary disorders of collecting duct sodium and potassium transport. In: Mount DB, Pollak MR, editor. Molecular and genetic basis of renal disease. Philadelphia, Saunders Elsevier, 2008:251-68.
|
41 |
Akcay A, Yavuz T, Semiz S, Bundak R, Demirdoven M. Pseudohypoaldosteronism type 1 and respiratory distress syndrome. J Pediatr Endocrinol Metab 2002;15:1557-61.
|
42 |
Bogdanovic R, Stajic N, Putnik J, Paripovic A. Transient type 1 pseudohypoaldosteronism: report on an eight-patient series and literature review. Pediatr Nephrol 2009;24:2167-75.
DOI
ScienceOn
|
43 |
Urbatsch A, Paller AS. Pustular miliaria rubra: a specific cutaneous finding of type I pseudohypoaldosteronism. Pediatr Dermatol 2002; 19:317-9.
DOI
ScienceOn
|
44 |
Martin JM, Calduch L, Monteagudo C, Alonso V, García L, Jorda E. Clinico-pathological analysis of the cutaneous lesions of a patient with type I pseudohypoaldosteronism. J Eur Acad Dermatol Venereol 2005;19:377-9.
DOI
ScienceOn
|
45 |
Kerem E, Bistritzer T, Hanukoglu A, Hofmann T, Zhou Z, Bennett W, et al. Pulmonary epithelial sodium-channel dysfunction and excess airway liquid in pseudohypoaldosteronism. N Engl J Med 1999;341:156-62.
DOI
ScienceOn
|
46 |
Malagon-Rogers M. A patient with pseudohypoaldosteronism type 1 and respiratory distress syndrome. Pediatr Nephrol 1999;13:484-6.
DOI
|
47 |
Rosler A. The natural history of salt-wasting disorders of adrenal and renal origin. J Clin Endocrinol Metab 1984;59:689-700.
DOI
|
48 |
Paver WK, Pauline GJ. Hypertension and hyperpotassaemia without renal disease in a young male. Med J Aust 1964;2:305-6.
|
49 |
Gordon RD, Geddes RA, Pawsey CG, O'Halloran MW. Hypertension and severe hyperkalaemia associated with suppression of renin and aldosterone and completely reversed by dietary sodium restriction. Australas Ann Med 1970;19:287-94.
DOI
|
50 |
Geller DS, Zhang J, Zennaro MC, Vallo-Boado A, Rodriguez-Soriano J, Furu L, et al. Autosomal dominant pseudohypoaldosteronism type 1: mechanisms, evidence for neonatal lethality, and phenotypic expression in adults. J Am Soc Nephrol 2006;17:1429-36.
DOI
ScienceOn
|
51 |
Greenberg D, Abramson O, Phillip M. Fetal pseudohypoaldosteronism: another cause of hydramnios. Acta Paediatr 1995;84:582-4.
DOI
ScienceOn
|